Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Development of a Core Outcome Domain Set for Facial Aging.
Journal: JAMA dermatology
Published: June 17, 2026
Practice Patterns and Geographic Distribution of Fellowship-Trained MD-PhD Mohs Surgeons in the United States.
Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Published: April 29, 2026
A phase 1 trial of HPV16 E7 T-cell receptor-engineered T cells in patients with relapsed/refractory HPV16-positive cancers (KITE-439 trial).
Journal: Frontiers in oncology
Published: February 11, 2026
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in Canada.
Journal: Current oncology (Toronto, Ont.)
Published: December 17, 2025
Short-term costs associated with outpatient use of axicabtagene ciloleucel in second-line and above relapsed/refractory large B-cell lymphoma based on the zuma-24 clinical trial.
Journal: Leukemia & lymphoma
Published: December 08, 2025
Classification of patients with relapsed/refractory large B-cell lymphoma who do not develop early CRS/NE toxicity using ZUMA clinical trial data.
Journal: Journal for immunotherapy of cancer
Published: July 11, 2025
Outpatient axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma: ZUMA-24 primary analysis.
Journal: American journal of cancer research
Published: May 19, 2025
Expanding the SIAH1-Associated Phenotypic Spectrum: Insights From Loss-of-Function Variants.
Journal: American journal of medical genetics. Part A
Published: January 05, 2025
Hypomagnesemia in lymphoma patients receiving CAR T therapy correlates with immune dysfunction and decreased survival.
Journal: Experimental hematology & oncology
Published: December 27, 2024
Immune Activation and Glycolytic Responses to Cutibacterium acnes Cell Wall Polysaccharides.
Journal: The Journal of investigative dermatology
Published: October 10, 2024
Radiomic features of PET/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacy.
Journal: Frontiers in oncology
Published: August 23, 2024
Durable response to CAR T is associated with elevated activation and clonotypic expansion of the cytotoxic native T cell repertoire.
Journal: Nature communications
Published: July 18, 2024
Last Updated: 09/26/2026